Spencer Ryan

CIK 00017779382 companiesEMERYVILLE, CA

SEC Profile

Transactions

Companies

Filings

CIK

0001777938

Recent Transactions

50 trades

Disposition to Issuer
DYNAVAX TECHNOLOGIES CORP$DVAX
Restricted Stock Units
2026-02-10−55,000→ 0 total
Disposition from Tender
DYNAVAX TECHNOLOGIES CORP$DVAX
Common Stock
2026-02-10−379,620→ 0 total
Award
DYNAVAX TECHNOLOGIES CORP$DVAX
Common Stock - Performance Stock Units
2026-02-10+165,000→ 165,000 total
Disposition to Issuer
DYNAVAX TECHNOLOGIES CORP$DVAX
Common Stock - Performance Stock Units
2026-02-10−165,000→ 0 total
Award
DYNAVAX TECHNOLOGIES CORP$DVAX
Common Stock - Performance Stock Units
2026-02-10+136,000→ 136,000 total
Disposition to Issuer
DYNAVAX TECHNOLOGIES CORP$DVAX
Common Stock - Performance Stock Units
2026-02-10−136,000→ 0 total
Disposition to Issuer
DYNAVAX TECHNOLOGIES CORP$DVAX
Stock Option (Right to Buy)
2026-02-10−50,000→ 0 total
Disposition to Issuer
DYNAVAX TECHNOLOGIES CORP$DVAX
Stock Option (Right to Buy)
2026-02-10−400,000→ 0 total
Disposition to Issuer
DYNAVAX TECHNOLOGIES CORP$DVAX
Stock Option (Right to Buy)
2026-02-10−130,000→ 0 total
Disposition to Issuer
DYNAVAX TECHNOLOGIES CORP$DVAX
Stock Option (Right to Buy)
2026-02-10−250,000→ 0 total
Disposition to Issuer
DYNAVAX TECHNOLOGIES CORP$DVAX
Restricted Stock Units
2026-02-10−90,667→ 0 total
Disposition to Issuer
DYNAVAX TECHNOLOGIES CORP$DVAX
Stock Option (Right to Buy)
2026-02-10−350,000→ 0 total
Disposition to Issuer
DYNAVAX TECHNOLOGIES CORP$DVAX
Stock Option (Right to Buy)
2026-02-10−280,000→ 0 total
Disposition to Issuer
DYNAVAX TECHNOLOGIES CORP$DVAX
Stock Option (Right to Buy)
2026-02-10−231,000→ 0 total
Disposition to Issuer
DYNAVAX TECHNOLOGIES CORP$DVAX
Stock Option (Right to Buy)
2026-02-10−225,000→ 0 total
Disposition to Issuer
Cidara Therapeutics, Inc.$CDTX
Stock Option (right to buy)
2026-01-07−4,250→ 0 total
Disposition to Issuer
Cidara Therapeutics, Inc.$CDTX
Stock Option (right to buy)
2026-01-07−11,100→ 0 total
Disposition to Issuer
Cidara Therapeutics, Inc.$CDTX
Stock Option (right to buy)
2026-01-07−2,125→ 0 total
Award
Cidara Therapeutics, Inc.$CDTX
Stock Option (right to buy)
2025-06-18+11,100→ 11,100 total
Exercise/Conversion
DYNAVAX TECHNOLOGIES CORP$DVAX
Common Stock
2025-02-18+55,000→ 297,261 total
Tax Payment
DYNAVAX TECHNOLOGIES CORP$DVAX
Common Stock
2025-02-18$12.93/sh−36,528→ 260,733 total
Exercise/Conversion
DYNAVAX TECHNOLOGIES CORP$DVAX
Restricted Stock Unit
2025-02-18−55,000→ 110,000 total
Exercise/Conversion
DYNAVAX TECHNOLOGIES CORP$DVAX
Restricted Stock Unit
2025-02-13−62,500→ 0 total
Tax Payment
DYNAVAX TECHNOLOGIES CORP$DVAX
Common Stock
2025-02-13$12.69/sh−31,694→ 242,261 total
Award
DYNAVAX TECHNOLOGIES CORP$DVAX
Stock Option (Right to Buy)
2025-02-13+225,000→ 225,000 total
Exercise/Conversion
DYNAVAX TECHNOLOGIES CORP$DVAX
Common Stock
2025-02-13+62,500→ 273,522 total
Award
DYNAVAX TECHNOLOGIES CORP$DVAX
Restricted Stock Unit
2025-02-13+136,000→ 136,000 total
Award
DYNAVAX TECHNOLOGIES CORP$DVAX
Restricted Stock Unit
2025-02-13+62,500→ 62,500 total
Exercise/Conversion
DYNAVAX TECHNOLOGIES CORP$DVAX
Common Stock
2025-02-10+20,833→ 222,231 total
Tax Payment
DYNAVAX TECHNOLOGIES CORP$DVAX
Common Stock
2025-02-10$13.20/sh−11,209→ 211,022 total
Exercise/Conversion
DYNAVAX TECHNOLOGIES CORP$DVAX
Restricted Stock Unit
2025-02-10−20,833→ 0 total
Award
Cidara Therapeutics, Inc.$CDTX
Stock Option (right to buy)
2024-07-18+2,125→ 2,125 total
Award
Cidara Therapeutics, Inc.$CDTX
Stock Option (right to buy)
2024-04-26+4,250→ 4,250 total
Award
DYNAVAX TECHNOLOGIES CORP$DVAX
Restricted Stock Unit
2024-02-15+165,000→ 165,000 total
Award
DYNAVAX TECHNOLOGIES CORP$DVAX
Stock Options (Right to Buy)
2024-02-15+231,000→ 231,000 total
Award
DYNAVAX TECHNOLOGIES CORP$DVAX
Common Stock
2024-02-15$9.45/sh+402→ 201,030 total
Tax Payment
DYNAVAX TECHNOLOGIES CORP$DVAX
Common Stock
2024-02-12$12.82/sh−11,684→ 200,628 total
Exercise/Conversion
DYNAVAX TECHNOLOGIES CORP$DVAX
Restricted Stock Unit
2024-02-10−20,833→ 20,833 total
Exercise/Conversion
DYNAVAX TECHNOLOGIES CORP$DVAX
Common Stock
2024-02-10+20,833→ 212,312 total
Tax Payment
DYNAVAX TECHNOLOGIES CORP$DVAX
Common Stock
2024-02-05$12.79/sh−17,129→ 191,479 total
Exercise/Conversion
DYNAVAX TECHNOLOGIES CORP$DVAX
Common Stock
2024-02-04+29,750→ 208,608 total
Exercise/Conversion
DYNAVAX TECHNOLOGIES CORP$DVAX
Restricted Stock Unit
2024-02-04−29,750→ 0 total
Exercise/Conversion
DYNAVAX TECHNOLOGIES CORP$DVAX
Common Stock
2023-02-27+9,888→ 157,855 total
Exercise/Conversion
DYNAVAX TECHNOLOGIES CORP$DVAX
Common Stock
2023-02-27+29,750→ 193,132 total
Tax Payment
DYNAVAX TECHNOLOGIES CORP$DVAX
Common Stock
2023-02-27$10.36/sh−14,673→ 178,459 total
Tax Payment
DYNAVAX TECHNOLOGIES CORP$DVAX
Common Stock
2023-02-27$10.36/sh−4,670→ 153,185 total
Exercise/Conversion
DYNAVAX TECHNOLOGIES CORP$DVAX
Common Stock
2023-02-27+20,834→ 174,019 total
Exercise/Conversion
DYNAVAX TECHNOLOGIES CORP$DVAX
Restricted Stock Unit
2023-02-27−29,750→ 29,750 total
Tax Payment
DYNAVAX TECHNOLOGIES CORP$DVAX
Common Stock
2023-02-27$10.36/sh−10,637→ 163,382 total
Exercise/Conversion
DYNAVAX TECHNOLOGIES CORP$DVAX
Restricted Stock Unit
2023-02-27−20,834→ 41,666 total

Companies

Recent Filings

Address

C/O DYNAVAX TECHNOLOGIES 2100 POWELL STREET, SUITE 720

EMERYVILLE, CA, 94608

View on SEC.gov